Skip to main content

Table 1 Baseline characteristics of the 40 subjects

From: A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis

Variable

 

Age, yrs

67.1 ± 5.7, 66.9 (63.7, 70.6)

Female(%)/Male(%)

23(57.5%) / 17 (42.5%)

Self-reported Ethnicity/Race

 

Non-Hispanic White

Other

37 (92.5%)

3 (7.5%)

Years since diagnosis

4.3 ± 3.9, 2.9 (1.3, 6.5)

FVC%

61.2 ± 11.9, 62.5 (55.5, 66.5)

DLCO%

52.6 ± 14.9, 50.5 (42.5, 65.5)

Supplemental Oxygen

 

Any use

Rest

Exertion

Sleep

31*

17

10

3

L-PF-35

 

Total

Symptoms

Dyspnea

Cough

Fatigue

Impacts

35.8 ± 18.6, 37.1 (21.0, 50.7)

31.8 ± 15.9, 32.4 (20.8, 43.3)

22.6 ± 18.5, 17.3 (9.2, 37.9)

37.5 ± 19.5, 35.0 (25.0, 50.0)

35.2 ± 22.7, 41.7(16.7, 50.0)

39.9 ± 23.2, 39.4 (18.1, 55.0)

SGRQ

 

Total

Symptoms

Activities

Impacts

45.8 ± 18.5, 49.9 (37.0, 58.2)

54.5 ± 19.4, 56.5 (40.9, 66.9)

60.6 ± 24.4, 66.5 (48.3, 79.7)

34.5 ± 19.0, 34.9 (20.3, 46.0)

UCSD SOBQ

43.5 ± 25.9, 48.5 (25.0, 63.5)

  1. Values = mean ± standard deviation or median (interquartile limits); *1 subject missing; FVC% = percentage of the predicted forced vital capacity; DLCO% = percentage of the predicted diffusing capacity of the lung for carbon monoxide; L-PF-35 = 35-item Living with Pulmonary Fibrosis Questionnaire; SGRQ = St. George’s Respiratory Questionnaire; UCSD SOBQ = University of California San Diego Shortness of Breath Questionnaire